Heart1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Heart News
Feature Story
 Education Center
Conditions
Procedures
Diagnostics
 Heart Attack Center
Prevention
Survivors
Dr. Tod Engelhardt  Heart
 Hero™

Dr. Tod Engelhardt:
Combating Major Blood Clots.
About Heroes
 Join the Discussion  in  Our Forums
 Community
Heart1 Forums
Patient Stories
 Reference
Online Resources
Video Library
advertisement
Search the Body1 Network
May 25, 2017  
HEART NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Hormone Rates Well Vs. Cardiac Arrest

    Hormone Rates Well Vs. Cardiac Arrest


    January 07, 2004

    A hormone called vasopressin is clearly better at saving the lives of patients whose hearts have stopped than the drug doctors have been using for the past 100 years, according to a study that could transform the treatment of sudden cardiac arrest.

    For a century, cardiac arrest victims have been given epinephrine, a synthetic adrenaline that constricts blood vessels and boosts blood pressure. It is often administered when shocking the heart with a defibrillator fails to revive the patient.

    Using vasopressin instead improved the chances of reaching a hospital alive by about 40 percent, and tripled the chances of going home from the hospital, in patients with the most deadly type of cardiac arrest, asystole, where all heart activity has stopped. Still, only 5 percent who got vasopressin made it home.

    The large European study was reported in Thursday's New England Journal of Medicine.

    The finding should soon change international guidelines for treating people in cardiac arrest outside a hospital, predicted lead researcher Dr. Volker Wenzel, associate professor of anesthesiology and critical care medicine at Leopold-Franzens University in Innsbruck, Austria.

    In an accompanying editorial, Dr. Kevin M. McIntyre of Harvard Medical School and Brigham and Women's Hospital in Boston called the findings "an important breakthrough." He noted that vasopressin does not appear to have the risks of epinephrine.

    "These advances should be translated into a new standard of care immediately," he said.

    Vasopressin, a synthetic hormone that narrows blood vessels, has been around for decades. A few years ago, the International Liaison Committee on Resuscitation revised its guidelines to add vasopressin as an alternative first drug. That was partly because epinephrine sometimes increases irregular rhythms and decreases oxygen supply to the brain after resuscitation.

    Each year, more than 600,000 people die of sudden cardiac arrest in North America and Europe, usually because of a heart attack or a heart rhythm disturbance.

    When medical personnel arrive, nearly 70 percent of victims have ventricular fibrillation, in which the heart's main pumping chambers flutter wildly and pump little blood. Less than 20 percent of these patients survive to go home.

    About 30 percent of victims, usually patients who have been down longer, have asystole, and nearly all die.

    The study involved 1,186 cardiac arrest patients treated in 33 communities in Austria, Germany and Switzerland from 1999 to 2002.

    After ambulance crews tried defibrillation, half the patients not resuscitated then got one or more injections of vasopressin and the other half got epinephrine. Patients in asystole did much better with vasopressin, but among other victims, outcomes were similar for the two drugs.

    Wenzel, co-chairman of the advanced cardiac life support committee of the European Resuscitation Council, said he expects that group and its counterparts in several nations to issue a joint position paper in several months recommending vasopressin as the first drug for patients in asystole.

    Wenzel will try to persuade his colleagues to go one step further and recommend injecting both vasopressin and epinephrine, because that showed the most benefit and saved eight crucial minutes.

    "If truly confirmed by another study it would be a major advancement in the treatment of asystole," said Dr. Muhamed Saric, director of echocardiography and cardiac stress testing at University of Medicine and Dentistry of New Jersey in Newark.

    One possible drawback, Saric noted, was that vasopressin patients might have been more likely to end up in a coma or vegetative state, because their brains were deprived of oxygen for too long before they were resuscitated.

    ---=

    On the Net: http://www.nejm.org

    http://www.americanheart.org


    Last updated: 07-Jan-04

    Comments

  • Add Comment
  •    
    Interact on Heart1

    Discuss this topic with others.
     
    Feature Archives

    Heart Disease Patients Need to Exercise to Benefit from the Protective Effects of Wine

    Effective Treatment for Heart Failure Possible Following Discovery of Heart Molecule

    Significant Decrease in Heart Disease after Prison Smoking Bans

    Heart Failure Patients Who Sleep Poorly Are at Double the Risk for Hospitalization

    Long-Term Survival Possible for Pediatric Heart Transplant Patients

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    The risk of cardiac death due to a lower ejection fraction

    The function of a defibrillator

    Plaques/fatty deposits as a cause for a heart attack

    More Features ...
     
    Related Content
    Fat Hormone May Cut Heart Attack Risk

    Medtronic Warns of Defibrillator Problems

    RA and Lupus Increase Heart Attack Risk

    Study: New Bypass Technique Holds Promise

    FDA Panel Cautiously Backs New Stent

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2017 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.